Mark Raffeld
Impact in
- Immunology top 5%
- interferon and immune responses
- Immune Response and Inflammation
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 6
- Genetics 2
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- ES Jaffe (2 shared papers)DL Longo (2 shared papers)Tomonori Yano (1 shared paper)Carolyn Harris (2 shared papers)HM Clark (2 shared papers)Takahiro Yano (1 shared paper)BARBARA KATHLEEN TEMECK (1 shared paper)M Melisse Sloas (1 shared paper)
- Journals
- Blood (4 papers)New England Journal of Medicine (1 paper)The American Journal of Surgical Pathology (1 paper)PubMed (1 paper)
- Partner nations
- United StatesMalaysiaGermany
In The Last Decade
Mark Raffeld
7 papers receiving 1.8k citations
Mark Raffeld's Hit Papers
Peers
Comparison fields: 5 of 60
- Immunology 972
- Pathology and Forensic Medicine 542
- Genetics 282
- Oncology 474
- Infectious Diseases 287
Countries citing papers authored by Mark Raffeld
This map shows the geographic impact of Mark Raffeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Raffeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Raffeld more than expected).
Fields of papers citing papers by Mark Raffeld
This network shows the impact of papers produced by Mark Raffeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Raffeld. The network helps show where Mark Raffeld may publish in the future.
Co-authors
The 21 scholars most cited alongside Mark Raffeld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Activated STING in a Vascular and Pulmonary Syndrome Hit paper breakdown → | 2014 | 1145 |
| 2 | 1993 | 348 | |
| 3 | 1992 | 217 | |
| 4 | 1995 | 70 | |
| 5 | Localization of the cell proliferation and apoptosis-associated CAS protein in lymphoid neoplasms. | 1997 | 47 |
| 6 | 1993 | 23 | |
| 7 | 1991 | 12 |
About Mark Raffeld
Mark Raffeld is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Immunology and Neurology, having authored 7 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Viral-associated cancers and disorders (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Retinoids in leukemia and cellular processes (1 paper), interferon and immune responses (1 paper), Cancer-related Molecular Pathways (1 paper), Immunotherapy and Immune Responses (1 paper) and CNS Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Immunology (972 citations), Pathology and Forensic Medicine (542 citations), Genetics (282 citations), Oncology (474 citations) and Infectious Diseases (287 citations). Mark Raffeld has collaborated with scholars based in United States, Malaysia and Germany. Frequent co-authors include ES Jaffe, DL Longo, Tomonori Yano, Carolyn Harris, HM Clark, Takahiro Yano, BARBARA KATHLEEN TEMECK, M Melisse Sloas, Harvey Ira Pass and Julie Teruya‐Feldstein. Their work appears in journals such as Blood, New England Journal of Medicine, The American Journal of Surgical Pathology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.